CN Patent

CN113710250A — 用左旋酮康唑治疗疾病的方法

Assigned to Strongbridge Dublin Ltd · Expires 2021-11-26 · 4y expired

What this patent protects

本文提供了一种向有需要的受试者施用左旋酮康唑或其药学上可接受的盐的方法，其中该受试者还正在被施用多药及毒素外排转运蛋白1(MATE1)底物或有机阳离子转运蛋白2(OCT2)底物。

USPTO Abstract

本文提供了一种向有需要的受试者施用左旋酮康唑或其药学上可接受的盐的方法，其中该受试者还正在被施用多药及毒素外排转运蛋白1(MATE1)底物或有机阳离子转运蛋白2(OCT2)底物。

Drugs covered by this patent

Patent Metadata

Patent number
CN113710250A
Jurisdiction
CN
Classification
—
Expires
2021-11-26
Drug substance claim
No
Drug product claim
No
Assignee
Strongbridge Dublin Ltd
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.